Bank of America’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-22
| Closed | – | – | 7536 |
|
2022
Q2 | $0 | Sell |
22
-136
| -86% | – | ﹤0.01% | 7766 |
|
2022
Q1 | $1K | Buy |
158
+132
| +508% | +$835 | ﹤0.01% | 7359 |
|
2021
Q4 | $0 | Sell |
26
-16,110
| -100% | – | ﹤0.01% | 7868 |
|
2021
Q3 | $179K | Buy |
16,136
+16,106
| +53,687% | +$179K | ﹤0.01% | 5535 |
|
2021
Q2 | $0 | Sell |
30
-22,190
| -100% | – | ﹤0.01% | 7375 |
|
2021
Q1 | $583K | Buy |
22,220
+21,685
| +4,053% | +$569K | ﹤0.01% | 4636 |
|
2020
Q4 | $19K | Sell |
535
-15,952
| -97% | -$567K | ﹤0.01% | 5834 |
|
2020
Q3 | $583K | Buy |
16,487
+15,683
| +1,951% | +$555K | ﹤0.01% | 4035 |
|
2020
Q2 | $35K | Buy |
804
+263
| +49% | +$11.4K | ﹤0.01% | 5529 |
|
2020
Q1 | $44K | Buy |
541
+149
| +38% | +$12.1K | ﹤0.01% | 5321 |
|
2019
Q4 | $37K | Sell |
392
-17
| -4% | -$1.61K | ﹤0.01% | 5515 |
|
2019
Q3 | $31K | Buy |
409
+222
| +119% | +$16.8K | ﹤0.01% | 5648 |
|
2019
Q2 | $19K | Buy |
+187
| New | +$19K | ﹤0.01% | 5800 |
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 6547 |
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6602 |
|
2018
Q2 | – | Sell |
-124
| Closed | -$12K | – | 6537 |
|
2018
Q1 | $12K | Buy |
+124
| New | +$12K | ﹤0.01% | 5816 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 6511 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 6514 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 6505 |
|
2016
Q1 | – | Sell |
-57
| Closed | -$7K | – | 6326 |
|
2015
Q4 | $7K | Buy |
57
+51
| +850% | +$6.26K | ﹤0.01% | 5782 |
|
2015
Q3 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 5793 |
|